| HYLG tracks an index that holds S&P 500 healthcare stocks and sells one-month, at-the-money call options on up to 50% of each stock. |
FUND BASICS
| Category |
US Equities |
| Fund Sponsor |
Global X |
| Website |
www.globalxetfs.com |
| Inception date |
Nov 21, 2022 |
| Assets (mns) |
$4 |
| Currency |
USD |
| Expense ratio |
60 bp |
| Distributions |
Monthly |
FUND STRUCTURE
| Regulation |
Open-Ended Fund |
| Custodian |
|
| Weighting |
Market Cap |
| Index replication |
|
| Uses derivatives |
Yes |
| Options available |
Yes |
CONSTITUENT BREAKDOWN
| No. of constituents |
0 |
| Wgt avg mkt cap (mns) |
$0 |
| Large cap (>$10bn) |
0.0% |
| Mid cap ($2-10bn) |
0.0% |
| Small cap (<$2bn) |
0.0% |
| Developed mkts |
0.0% |
| Emerging mkts |
0.0% |
TOP TEN HOLDINGS
|
0.0 % |
Total |
0.0 % |
TOP COUNTRY EXPOSURE
 |
|
0.0 % |
Standardized Annual Returns (thru February 28)
| Year-to-date |
1 year |
5 years |
10 years |
Since Incep. |
| 4.4% |
20.0% |
-- |
-- |
12.5% |
Market Correlations
| versus... |
Beta |
R-squared |
| S&P500 |
0.75 |
69% |
| MSCI EAFE |
0.58 |
56% |
| MSCI Emg. Mkts. |
0.40 |
24% |
Technical Indicators
| Recent close |
$29.63 |
| 30d moving avg. |
$29.16 |
| Annualized volatility |
11.3% |
| Short interest (ETF) |
2.5% |
| Relative strength (RSI) |
59 |
Liquidity measures
| Avg. volume (thou.) |
1 |
| Turnover |
0.7% |
| Bid/Ask (% of price) |
0.45% |
| ADV underlying (mns) |
$11,146 |
 |
There were no matches found with other funds under coverage. |
Content on this tab for subscribers only**
| |
2020 |
2021 |
2022 |
2023 |
2024 |
2025E |
2026E |
| Sales per share |
** |
** |
** |
** |
** |
** |
** |
| Earnings per share |
** |
** |
** |
** |
** |
** |
** |
Dividends per share  |
** |
** |
** |
** |
** |
** |
** |
| Book value per share |
** |
** |
** |
** |
** |
** |
** |
| Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| Long term EPS growth est. |
**% |
|
Debt-to-equity |
**x |
| Asset turnover |
**% |
|
Assets-to-equity |
**x |
Revision activity*
|
| *Six months ago = 100 |
Compound annual growth rates
|
Content on this tab for subscribers only
| |
2024 |
2025E |
2026E |
| Price-to-sales |
** |
** |
** |
| Price-to-earnings |
** |
** |
** |
| Price-to-cash flow |
** |
** |
** |
| Price-to-growth |
** |
** |
** |
| Price-to-book value |
** |
** |
** |
| Yield |
** |
** |
** |
AVOID |
| Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
| Calculation of ALTAR Score™ |
| Avg. Return on Equity |
0.0 |
% |
| Divided by: Fwd. P/BV |
0.0 |
x |
| Less: Expense ratio |
60 |
bp |
| Equals: ALTAR Score |
0.0 |
% |
|
| More information on ALTAR Score™ |
|
|
|
Fundamentals